comparemela.com

Dae Woo Park News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India

Press release content from Business Wire. The AP news staff was not involved in its creation.

South koreaSri lankaMihyeon jeongSyd daftaryHyungoo kangNamita narkarBharat daftaryCross labcellRivaara immune privateJgc holdingsRivaara immune private limitedRivaara immuneDae woo parkMiddle eastImmune cell therapyDrug designation

GC Cell Licenses Liver Cancer Cell Therapy to Rivaara Immune in India

South Korea-based GC Cell and India-based Rivaara have inked a licensing agreement to commercialize the autologous treatment in India, Sri Lanka, and Bangladesh.

Sri lankaDrug administrationRivaara immuneGreen cross cellDae woo parkMiddle east

vimarsana © 2020. All Rights Reserved.